Request a Proposal  
Blog Feature

By: Admin
January 12th, 2016

Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, is proud to announce its expansion of Phase I-IV clinical trial services into the Asia-Pacific region. This expansion includes the opening of legal entities in Vietnam, Philippines, South Korea, Malaysia, Thailand and Taiwan.

Blog Feature

By: Admin
December 20th, 2015

Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, is proud to announce the promotion of Natalie Gassen to the position of Chief Financial Officer.

GDPR_Checklist-cover

Join other Clinical Development experts to get the latest industry news, trends and insights.

As a thank you for subscribing, you'll receive a free copy of our GDPR Controller & Processor Checklist

Blog Feature

By: Admin
October 13th, 2015

Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization (CRO) to biopharmaceutical and device industries, is proud to announce the relocation of its Polish location to a larger office to accommodate for its growing staff.

Blog Feature

By: Admin
June 11th, 2015

HOUSTON, TEXAS – Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization (CRO) to biopharmaceutical and device industries, is proud to announce the opening of a new, fully-staffed office in Paris, France.

Blog Feature

By: Admin
March 12th, 2015

Bioavailability and Bioequivalence (BA/BE) studies require samples of investigational product retained. Typically, this is performed manually and overseen by clinical monitors during site initiation. This manual approach is feasible for limited sites, but larger site numbers make manual retention less feasible. This case study reviews Pharm-Olam's Automated Sample Retention Solution that was used in a recent study. To read the complete case study click here.

Blog Feature

By: Admin
February 12th, 2015

Pharm-Olam was selected to provide development services for a Phase III study, which was designed to address the efficacy and safety for a compound for pulmonary arterial hypertension patients. Pharm-Olam was responsible for: The recruitment of 192 patients Management of 17 sites in Russia, Belarus, and Ukraine All regulatory, project management, and monitoring services To view the case study and the lessons learned in this study, click here

Blog Feature

By: Admin
January 12th, 2015

To learn more about the benefits that Pharm-Olam offers click here to view the video.

Blog Feature

By: Admin
November 13th, 2014

The Ukraine has been a hot topic in the news due to the recent turmoil in the country. Even during these difficult times, drug development and clinical trials continue to be run in the Ukraine, which boasts recruitment figures at least two times higher than those in the United States and Western Europe. To view a recording of this webinar, click here